On Wednesday 26 April, the European Commission proposed an ambitious revision of the European Union’s pharmaceutical legislation in order to create a single market for medicines, reduce authorisation time for medicines and step up the fight against antimicrobial resistance (AMR) and the presence of pharmaceuticals in the environment.
This revision is the first major update of the pharmaceutical legislation since 2004. It will adapt legislation to the needs of the 21st century.
The reform...